Vincent Fert has a master’s degree in immunology of the University of Marseilles, France.
Prior to founding Ipsogen in 1999, Vincent Fert held different executive positions at Immunotech. He was first responsible for R&D, then license acquisition and business development.
Vincent is the author of 15 scientific publications and 9 patents. After Immunotech was acquired by Beckman-Coulter (USA), in 1996, Vincent joined the ‘Advanced Technology Centre’ in Brea, CA where he led technology research projects.
In 1999, with Industry managers, scientists and physicians, Vincent founded Ipsogen, Marseilles, France to develop and market innovative diagnostic tools in order to tailor cancer treatments. Stéphane Debono, Chief Operating Officer and member of Ipsogen Executive Committee, cofounder
Stéphane Debono graduated at ESIM (now the Ecole Centrale Marseille) with a specialization in industrial computer science.
Prior to co-founding Ipsogen in 1999, Stéphane Debono worked as a bioinformatics scientist and manufacturing engineer at Beckman Coulter, Immunotech for 2 years.
After 6 years as CTO in Bioinformatics and Administrative Manager, Stéphane is currently COO of the Company, being responsible for the development, design, and improvement of the systems that create and deliver Ipsogen SA and Ipsogen, Inc. products and services, including molecular diagnostic kits manufacturing.
He is the director of the human resource department and manages the general operations of the company. Susan Hertzberg, President and CEO Ipsogen Inc. and Vice President Corporate Business Development for Ipsogen SA and member of Ipsogen Executive Committee
During her career, Ms. Hertzberg has been a strategic driver of growth and profitability and has held many executive positions.
Immediately prior to joining Iposgen, Ms. Hertzberg served as General Manager, Global Accounts at Abbott Diagnostics.
Before that, she spent much of her career at Quest Diagnostics and progressed through many management and leadership positions, including, Vice President, Purchasing and Materials Management, and Vice President, Marketing.
Susan Hertzberg also has deep Payor experience, both on the lab and managed care side, and was a Director at Oxford Health Plans. In 1997, she received an MBA from Columbia University, NY. 
Hélène Peyro-Saint-Paul, Chief Medical Officer and member of Ipsogen Executive Committee
During her career, Hélène Peyro-Saint-Paul has held a number of executive positions in the industry; she contributed to the development and launch of several innovative molecules.
Immediately prior to joining Ipsogen in late 2008, she was European Neuro-Psychiatry Medical Lead at Bristol-Myers Squibb European Neuro-Psychiatry Medical Lead at Bristol-Myers Squibb. Before that, Hélène Peyro-Saint-Paul served as European Medical Affairs Director, then Strategic Marketing Director for metabolic diseases at Actelion. As International Medical Affairs Director at Serono, she contributed to the launch and reimbursement of Rebif®, a reference treatment for multiple sclerosis, in Europe and the United States.
Hélène Peyro-Saint-Paul holds a doctorate in Medicine (Neurology) from Toulouse University, a degree in Molecular Genetics and a Master in Neuroscience from Paris VI University. Since joining the pharmaceutical industry, she has developed her expertise in pharmaco-economics and received an Executive MBA from ESSEC in 2000.
Pascale Boissel, Chief Financial Officer and member of Ipsogen Executive Committee
HEC graduate and chartered accountant, Pascale Boissel started her career by joining one of the Big Four audit companies, Price Waterhouse Coopers.
After 4 years in auditing and corporate finance consultancy, she has since spent most of her time working for large listed groups with broad international exposure, mainly in the Danone and Lafarge Groups. During this time, her career has been centered on managing teams and projects in reporting process improvement, business control and external development project evaluation.
With dedicated know-how in improving processes and projects for innovative organizations and reporting, Ms. Boissel has solid experience in international accounting and internal auditing standards.
Her strong experience and skills will be of major importance in helping the team drive IPSOGEN’s growth. Corinne Danan, Vice President Commercial Operations
Corinne Danan has joined Ipsogen in 2010 to develop the company presence in Europe and rest of the world.
Prior to joining Ipsogen, Corinne was European Director for Monogram Biosciences – A company from California, specialized in individualized Medicine - leading the efforts for successful introduction of Trofile assay as companion diagnostic of Pfizer’s HIV drug, in close relationships with Pfizer’s European Commercial team.
Before joining the Diagnostic industry, Corinne worked 16 years with Eli Lilly, serving in various roles including Senior Sales & Marketing roles, and Country General Management.
Corinne holds a business degree from ISC and a Master of Business & Administration from INSEAD. Fabienne Hermitte, R&D and Regulatory Affairs Director, cofounder
Prior to co-founding Ipsogen in 1999, Fabienne Hermitte worked for a CNRS-Rhône-Poulenc team.
After 6 years as CTO in Molecular Biology, Fabienne Hermitte is currently in charge of the R&D and Regulatory Affairs of the company, being responsible for the Blood and Breast Cancer research & development programs, of external collaborations (ELN, COBRED, etc.), and also in charge of the relation with regulatory agencies (FDA, AFSSaPS) to register in vitro diagnostic tests.
She holds a Ph.D. and graduated from the IFSBM in 1997 (IGR, Villejuif, France), and the INA-PG ‘Agro’ in 1994. Catherine Gerbon, ‘Blood Cancers’ Marketing Director
Catherine Gerbon joined Ipsogen in 2003 as blood cancer Product Manager.
She now heads marketing for this series of products and manages Ipsogen's distribution network worldwide.
Catherine Gerbon has a degree in Health and Biology from the Science University of Montpellier, France and a MBA from IAE, Aix-en-Provence, France.
Catherine Gerbon has worked for several applied research laboratories prior to joining Ipsogen. Denis Meshaka, Intellectual Property and Licensing Director
Denis Meshaka is in charge of Ipsogen’s intellectual propriety and licencing.
Prior to joining Ipsogen in 2002, Denis Meshaka worked as a consultant within EGYP, Intellectual Property Attorneys (Paris) where he managed IP and licensing for French research institutes including INSERM, Institut Pasteur.
Denis Meshaka also worked at Novartis (Basel, CH) where he was in charge of the galenic development portfolio for cardiovascular diseases, bone metabolism and nervous system.
He has a scientific background (molecular biology and organic chemistry).
Denis Meshaka also holds a Master’s in International IP Law and a general MBA from IAE, Aix-en-Provence, France. Béatrice Roger, Quality Assurance Director
Béatrice Roger is Director of Quality Assurance. She joined the company in May 2003.
She holds a Ph.D. in Health Biology from the University Montpellier 1, France and a degree in Quality-Security-Environment Management.
Prior to joining Ipsogen, Béatrice Roger worked as a biology molecular researcher within laboratories of the Pasteur Institute and INSERM.
Agnès Martinec, Lab Operations Director
Agnès Martinec, Ph.D (molecular biology) joined Ipsogen in December 2001 as a project manager in charge of the partnerships (breast cancer R&D) and Ipsogen’s services activities.
In 7 years she has acquired a great know-how in sample handling (pre-analytical processing, analysis on DNA chips, sequencing ...) and sample logistics (collection, storage and transport of samples) in national and international multicentric clinical trials.
Agnes Martinec is now Lab Operations Director responsible for the MapQuant Dx production process.
|
|
